About Phesi
Phesi is a global provider of patient-centric data science solutions for clinical development, serving pharmaceutical and life sciences companies. The company's award-winning Trial Accelerator™ platform is powered by the world's largest clinical trials database, containing real-world data from over 325 million patients across 232 countries and territories, drawn from 719,183 clinical research projects and 22 global registries. Phesi's AI-driven solutions enable sponsors to optimize protocol design, create Digital Patient Profiles and Digital Twins, select high-performing investigator sites and countries, and generate Digital Trial Arms as external controls. By connecting real-world patient data with trial execution data, Phesi helps life sciences companies eliminate costly trial failures and protocol amendments, improve patient population accuracy and diversity, reduce trial timelines and patient burden across every stage of clinical development for any indication, including rare diseases. The company's proprietary integrated methodology and AI technologies analyze over 485,000 curated clinical trials, 4.2 million physicians, and 4,000+ disease indications. Phesi's approach transforms clinical development into a data-driven science, enabling predictive modeling across four key views: Patient Profile, Trial Performance, Country, and Investigator Site. The platform generates reliable evidence for drug development and commercialization without the expense or time required in traditional trials, helping pharmaceutical companies make more informed decisions and accelerate the path from research to market.
Mission & Story
Mission
Patient-centric data analytics to simulate clinical development and improve outcomes. Smarter trials, faster cures.
Founding Story
Founded by Dr. Gen Li, who serves as President and Founder. The company was established to address systemic issues in drug development by connecting real-world patient data with clinical trial design and execution.
Clinical Focus
Medical conditions and clinical areas addressed by Phesi.
Who It Serves
Milestones & Awards
Recent Milestones
Won 2025 Clinical Trials Arena Excellence Award for Innovation (November 2025). Took leading position on Frost and Sullivan's Frost Radar™ for AI-enabled clinical trials (February 2026). Published major analysis of 600,000+ clinical trial protocols (May 2026).
Awards & Recognition
2025 Clinical Trials Arena Excellence Award for Innovation. Leading position on Frost and Sullivan's Frost Radar™ for AI-enabled clinical trials (2026). Described as award-winning solutions.
Key Partnerships
Company Details
- Headquarters
- Boston, MA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.